Byoung Chul Cho, M.D., Yonsei Cancer Center discusses NSCLC With M7824 Second Line Therapy. At ESMO Oncology Conference – Munich, Germany On October 19, 2018.
NSCLC With M7824 Second Line Therapy
Byoung Chul Cho, M.D., Yonsei Cancer Center discusses NSCLC With M7824 Second Line Therapy. At ESMO Oncology Conference – Munich, Germany On October 19, 2018.